PhagePro has been selected for the 2020 NIH I-Corps Program. We’re looking forward to conducting 100 interviews with experts in the field!
Congratulations to PhagePro’s CEO and co-founder, Dr. Minmin Yen, for winning the Innovations Pitch Competition at the annual ASTMH meeting!
PhagePro’s CEO and co-founder, Dr. Minmin Yen, was selected to be one of the Gilead Sciences sponsored U.S. delegates at the One Young World Summit in London. Congratulations to Mimi and all the other delegates! We’re excited to work together on tackling some of the world’s most pertinent issues.
Exciting news for PhagePro’s co-founder, Dr. Andrew Camilli! He was honored at the Tufts University Inventor Recognition Event for his work on phage therapy.
Congratulations to PhagePro’s CEO and co-founder, Dr. Minmin Yen! She has been selected as one of The Capital Network’s 2019 Female Founder Fellows.
Excited to announce, Dr. Gabrielle Grandchamp, has joined our team at PhagePro as our Principal Scientist! Gabrielle received her doctoral degree from the Microbiology Department at UNC, Chapel Hill and will be working to help us develop our phage therapy.
PhagePro was selected as a RESI Pitch Challenge finalist! We’re looking forward to pitching with the other finalists.
Excited to announce PhagePro won Lab Central’s Big Pitch Competition!
Read more about how PhagePro is working to prevent cholera infections using phage therapy. Thanks Tufts Magazine for sharing!
Our CEO and co-founder, Dr. Minmin Yen, was featured on the podcast @Importantnotimp. Hear more about phage therapy and our startup on episode #41.
PhagePro’s CEO and co-founder, Dr. Minmin Yen, has been named to MIT Technology Review’s annual list of 35 Innovators Under 35 as a humanitarian. Congratulations, Dr. Yen!
PhagePro has moved into our new space at Tufts Launchpad. We’re excited to join the BioLabs community!